[20210301]IN11560_2019冠状病毒疾病疫苗和辅助接种材料的Warp-Speed行动合同.pdf

CRS INSIGHT Prepared for Members and Committees of Congress INSIGHTINSIGHTi i Operation Warp Speed Contracts for COVID-19 Vaccines and Ancillary Vaccination Materials Updated March 1, 2021 Operation Warp Speed (OWS) is an interagency partnership between the Department of Health and Human Services (HHS) and the Department of Defense (DOD) that coordinates federal efforts to accelerate the development, acquisition, and distribution of COVID-19 medical countermeasures. Collaborating HHS components include the Centers for Disease Control and Prevention (CDC), the National Institutes of Health (NIH), and the Biomedical Advanced Research and Development Authority (BARDA). OWS is a Trump Administration initiative, and while the Biden Administration has indicated that the interagency response to COVID-19 will continue, it plans to restructure and rename the effort. Although the stated goals of OWS include therapeutics and diagnostics, most of the money awarded to date has focused on vaccines. This Insight summarizes OWSs vaccine-related contracts, including those for ancillary vaccination materials (e.g., needles and vials). BARDA is currently supporting six vaccine candidates through fund